World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02238574
Date of registration: 09/09/2014
Prospective Registration: Yes
Primary sponsor: Maastricht University Medical Center
Public title: Diagnostics for the Treatment of Progressive Mucosal Lesions of the Oral Cavity: a Prospective Study
Scientific title: Chromosomal Instability as an Indicator for the Treatment of Progressive Mucosal Lesions of the Oral Cavity.
Date of first enrolment: December 8, 2014
Target sample size: 0
Recruitment status: Withdrawn
URL:  https://clinicaltrials.gov/show/NCT02238574
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Netherlands
Contacts
Name:     Maarten Borgemeester, MD
Address: 
Telephone:
Email:
Affiliation:  University medical centre Maastricht
Key inclusion & exclusion criteria

Inclusion Criteria:

- subjects =18 years

- premalignant lesions of the oral cavity, classified as hyperkeratosis, hyperplasia,
mild or moderate dysplasia

- written informed consent

Exclusion Criteria:

- former malignancy or lesion classified as severe dysplasia or carcinoma in situ at the
same anatomical localization of the oral cavity

- lesions within an anatomical field which has been exposed to former treatment (e.g.
radiotherapy)

- insufficient biopsy material to perform additional FISH analysis

- pregnancy, because of the physical burden (e.g. extra general anesthesia) in this
study setting



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Chromosomal Instability
Low Grade Dysplasia Oral Cavity
Loss of Heterozygostiy
Fluorescence In Situ Hybridization
Intervention(s)
Other: follow up
Procedure: surgery
Primary Outcome(s)
Number of patients (CIN negative and positive) who will show progression to malignancy of the oral cavity. [Time Frame: 1 year]
Secondary Outcome(s)
Number of patients (LOH negative and positive) who will show progression to malignancy of the oral cavity. [Time Frame: 1 year]
Secondary ID(s)
NL46343.068.13
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history